World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
63
Citations
18535
World Ranking
2990
National Ranking
1405

Mary Glenn Fowler publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Mary Glenn Fowler sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 240 publications — 48th percentile

48% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Mary Glenn Fowler D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Mary Glenn Fowler sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 63 D-Index — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Mary Glenn Fowler is affiliated with Johns Hopkins University in the United States and has contributed extensively to the field of medicine, with a primary focus on infectious diseases. Their research spans multiple subfields including infectious diseases, emergency medicine, obstetrics and gynecology, epidemiology, and pediatrics, perinatology, and child health.

The main areas of study in their work include:

  • HIV/AIDS Research and Interventions
  • HIV-related health complications and treatments
  • Adolescent Sexual and Reproductive Health
  • Global Maternal and Child Health
  • HIV/AIDS drug development and treatment
  • HIV Research and Treatment
  • COVID-19 Impact on Reproduction

Their recent publications highlight research on both HIV and COVID-19, with notable papers such as:

  • "Assessment of Clinical Outcomes Among Children and Adolescents Hospitalized With COVID-19 in 6 Sub-Saharan African Countries" (2022) published in JAMA Pediatrics
  • "Association of Maternal Viral Load and CD4 Count With Perinatal HIV-1 Transmission Risk During Breastfeeding in the PROMISE Postpartum Component" (2021) published in JAIDS Journal of Acquired Immune Deficiency Syndromes
  • "Pregnancy Outcomes of Women Conceiving on Antiretroviral Therapy (ART) Compared to Those Commenced on ART During Pregnancy" (2020) published in Clinical Infectious Diseases
  • "Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Pregnancy in Sub-Saharan Africa: A 6-Country Retrospective Cohort Analysis" (2022) published in Clinical Infectious Diseases
  • "Maternal Human Immunodeficiency Virus (HIV) Drug Resistance Is Associated With Vertical Transmission and Is Prevalent in Infected Infants" (2021) published in Clinical Infectious Diseases

Frequent publication venues for their work include:

  • JAIDS Journal of Acquired Immune Deficiency Syndromes
  • PLoS ONE
  • AIDS
  • Clinical Infectious Diseases
  • BMC Infectious Diseases

Their collaborative network includes several frequent coauthors, among them:

  • Taha E. Taha
  • Sean S. Brummel
  • Philippa Musoke
  • Lynda Stranix-Chibanda
  • Sufia Dadabhai

Mary Glenn Fowler's research contributions primarily focus on understanding HIV/AIDS transmission, treatment, and related maternal and child health issues, alongside exploring the impact of COVID-19 on reproductive health in sub-Saharan Africa. Their work blends clinical outcomes analysis with epidemiological data to address urgent public health challenges in infectious diseases and maternal-child health contexts.

Best Publications

  • Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

    Laura A Guay;Philippa Musoke;Thomas Fleming;Danstan Bagenda

  • Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice.

    Kevin M. De Cock;Mary Glenn Fowler;Eric Mercier;Isabelle de Vincenzi

  • RISK FACTORS FOR PERINATAL TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 IN WOMEN TREATED WITH ZIDOVUDINE

    Lynne M. Mofenson;John S. Lambert;E. Richard Stiehm;James Bethel

  • Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial

    J. Brooks Jackson;Philippa Musoke;Thomas Fleming;Thomas Fleming;Laura A. Guay

  • The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies.

    W. Andiman;M. Boucher;D. Burns;Y. Bryson

  • Obstetrical Factors and the Transmission of Human Immunodeficiency Virus Type 1 from Mother to Child

    Sheldon H. Landesman;Leslie A. Kalish;David N. Burns;Howard Minkoff

  • Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).

    Susan H. Eshleman;Martin Mracna;Laura A. Guay;Martina Deseyve

  • Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission

    Newton I. Kumwenda;Donald R. Hoover;Lynne M. Mofenson;Michael C. Thigpen

  • Lack of Long-term Effects of In Utero Exposure to Zidovudine Among Uninfected Children Born to HIV-Infected Women

    Mary Culnane;Mary Glenn Fowler;Sophia S. Lee;George McSherry

  • Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention

    Mary G. Fowler;Min Qin;Susan A. Fiscus;Judith S. Currier

  • Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention

    Mary G. Fowler;Min. Qin;Susan A. Fiscus;Judith S. Currier

  • Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa

    Elliot Marseille;James G Kahn;Francis Mmiro;Laura Guay

  • School functioning of US children with asthma.

    Mary Glenn Fowler;Marsha G. Davenport;Rekha Garg

  • Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials.

    Six Week Extended-Dose Nevirapine (Swen) Study Team;Abubaker Bedri;Berhanu Gudetta;Abdulhamid Isehak

  • Predictive Value of Quantitative Plasma HIV RNA and CD4 + Lymphocyte Count in HIV-Infected Infants and Children

    Paul E. Palumbo;Claire Raskino;Susan Fiscus;Savita Pahwa

  • Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission.

    J. B. Jackson;G. Becker-Pergola;L. A. Guay;P. Musoke

  • A phase I / II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006).

    Philippa Musoke;Laura A. Guay;Danstan Bagenda;Mark Mirochnick

  • Triple-Antiretroviral Prophylaxis to Prevent Mother-To- Child HIV Transmission through Breastfeeding—The Kisumu Breastfeeding Study, Kenya: A Clinical Trial

    Timothy K. Thomas;Timothy K. Thomas;Rose Masaba;Craig B. Borkowf;Richard Ndivo

  • Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission.

    Evelyn Rodriguez;Lynne Mofenson;Bei-Hung Chang;Kenneth Rich

  • Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.

    Joann Schulte;Ken Dominguez;Thomas Sukalac;Beverly Bohannon

  • Zidovudine, Didanosine, or Both as the Initial Treatment for Symptomatic HIV-Infected Children

    Janet A. Englund;Carol J. Baker;Claire Raskino;Ross E. Mckinney

  • Prevention of HIV-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in HIV-1-Infected Women With High CD4 Cell Count (IMPAACT PROMISE): A Randomized, Open-Label, Clinical Trial.

    Patricia M. Flynn;Taha E. Taha;Mae. Cababasay;Mary Glenn. Fowler

  • Efficacy of Zidovudine and Human Immunodeficiency Virus (HIV) Hyperimmune Immunoglobulin for Reducing Perinatal HIV Transmission from HIV-Infected Women with Advanced Disease: Results of Pediatric AIDS Clinical Trials Group Protocol 185

    E. Richard Stiehm;John S. Lambert;Lynne M. Mofenson;James Bethel

Frequent Co-Authors

Lynne M. Mofenson
Lynne M. Mofenson Elizabeth Glaser Pediatric AIDS Foundation
Taha E. Taha
Taha E. Taha Johns Hopkins University
J. Brooks Jackson
J. Brooks Jackson University of Iowa Hospitals and Clinics
Susan H. Eshleman
Susan H. Eshleman Johns Hopkins University School of Medicine
Patricia M. Flynn
Patricia M. Flynn St. Jude Children's Research Hospital
Donald R. Hoover
Donald R. Hoover Rutgers, The State University of New Jersey
Judith S. Currier
Judith S. Currier University of California, Los Angeles
Edward N. Janoff
Edward N. Janoff University of Colorado Denver
Kenneth McIntosh
Kenneth McIntosh Boston Children's Hospital
Denise J. Jamieson
Denise J. Jamieson Emory University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career pathways. Nurses looking to enhance their expertise often consider programs like the fnp to acnp bridge program online, which facilitates transitioning from Family Nurse Practitioner roles to Acute Care Nurse Practitioner positions. This can significantly broaden clinical opportunities within immunology and specialized patient care.

Accelerated programs are ideal for those seeking faster entry into advanced practice roles. The accelerated fnp programs enable students to obtain their Family Nurse Practitioner credentials efficiently, which is valuable for integrating immunology principles into advanced nursing practice.

For individuals without a nursing background aiming to enter the field, 12-month accelerated nursing programs online for non nurses offer a quick pathway to foundational nursing qualifications. These programs provide essential clinical knowledge applicable to immunology-related healthcare roles.

Understanding compensation is also crucial for career planning. The availability of dnp salary transparency helps prospective students and professionals make informed decisions about investments in education and potential financial outcomes in immunology-focused nursing careers.

Best Scientists Citing Mary Glenn Fowler

Trending Scientists

Recently Published Articles